Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Trials & R&D · first seen yesterday, updated yesterday

First of Amgen’s Phase III Sjögren’s disease trials succeeds

1 outlet Amgen

Amgen is running a second Phase III study of dazodalibep in Sjögren's disease as it eyes a spot in a lacking market. The post First of Amgen’s Phase III Sjögren’s disease trials succeeds appeared first on Clinical Trials Arena .

Summary from Clinical Trials Arena.

Coverage 1 article · 1 outlet

  1. Clinical Trials Arena
    First of Amgen’s Phase III Sjögren’s disease trials succeeds